Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Trinity Biotech (TRIB) Return on Sales (2016 - 2024)

Trinity Biotech's Return on Sales history spans 16 years, with the latest figure at 0.01% for Q4 2024.

  • On a quarterly basis, Return on Sales fell 1.0% to 0.01% in Q4 2024 year-over-year; TTM through Dec 2024 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.01%, down 1.0% from a year prior.
  • Return on Sales hit 0.01% in Q4 2024 for Trinity Biotech, down from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for TRIB hit a ceiling of 0.0% in Q3 2020 and a floor of 0.01% in Q2 2023.
  • Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2023.
  • Biggest five-year swings in Return on Sales: decreased -1bps in 2022 and later rose 1bps in 2024.
  • Tracing TRIB's Return on Sales over 5 years: stood at 0.0% in 2020, then plummeted by -155bps to 0.0% in 2021, then plummeted by -285bps to 0.01% in 2022, then soared by 40bps to 0.0% in 2023, then plummeted by -148bps to 0.01% in 2024.
  • Business Quant data shows Return on Sales for TRIB at 0.01% in Q4 2024, 0.0% in Q3 2024, and 0.0% in Q2 2024.